O
OrthoSpace
Innovative balloon technology for rapid rotator cuff repair, minimizing surgery time and enhancing recovery
About OrthoSpace
OrthoSpace is a medical technology company specializing in minimally invasive solutions for rotator cuff injuries. The company operates in the healthcare sector, focusing on patients with shoulder injuries, particularly those involving the rotator cuff. OrthoSpace's core product is a CE-approved balloon implant that is quickly deployed between the acromion and the caudal structures, offering a viable alternative to major surgery. This innovative solution aims to reduce pain and improve the range of motion for patients, significantly shortening recovery times.
Read full description
OrthoSpace primarily serves orthopedic surgeons and their patients, providing a cutting-edge option for those suffering from rotator cuff tears. The company's business model revolves around the development, clinical testing, and commercialization of its balloon technology. Revenue is generated through the sale of these medical devices to healthcare providers and institutions.
The market for OrthoSpace's products includes hospitals, clinics, and specialized orthopedic centers globally. By offering a less invasive and quicker recovery option, OrthoSpace addresses a significant need in the orthopedic market, particularly for aging populations and active individuals prone to shoulder injuries.
At a glance
- Status
- Acquired
- Founded
- 2009
- Headquarters
- Caesarea, Israel
- Employees
- 12
- Open positions
- None listed
- Dealroom signal
- 71.5/100
- Industry
- Health
- Sub-industry
- Pharmaceutical, Medical Devices
- Sector
- Biotech & Life Sciences, Rehabilitation, Biotechnology, medical implants, Surgery, Biodegradable, Orthopedic, Surgical Equipment, Tech for Hospitals and Clinics, Biotech and Pharma
- Business model
- Manufacturing
- Client focus
- b2b
Latest news
Press, funding announcements and product moves mentioning OrthoSpace.
Funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| ACQUISITION✓Exit | Mar 2019 | $220M | $220M | Stryker | — |
| EARLY VC✓Equity / VC | Dec 2016 | $7M | $28M | TriVentures · Johnson & Johnson · Smith & Nephew · HealthpointCapital | ↗ |
Growth signals
Latest recorded traffic for OrthoSpace is 170 monthly website visits, up 466.7% over the last three months. OrthoSpace's team declined 25% over the past year.
Similar companies
Company identity and context are open; selected comparison metrics preview what is available on the platform.
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Series A4 investors entered at this stage
HealthpointCapital
TriVentures
Smith & Nephew
Johnson & Johnson
Other known investors3 additional known investors
Stryker
BioStar Capital
InnovaHealth Partners
Source: Dealroom Talent Intelligence.
Global footprint
team presence
Market sentiment
An AI-synthesised read of the highest-engagement posts about OrthoSpace on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See OrthoSpace’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.